These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 6159391)

  • 21. Dual actions of glucagon: direct stimulation and indirect inhibition of dog pancreatic secretion.
    Horiuchi A; Iwatsuki K; Ren LM; Kuroda T; Chiba S
    Eur J Pharmacol; 1993 Jun; 237(1):23-30. PubMed ID: 7689468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of inhibition of pancreatic secretion by the beta-adrenergic agonist, terbutaline.
    Joehl RJ
    Pancreas; 1986; 1(3):232-8. PubMed ID: 2437567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucagon inhibition of secretin and combined secretin and cholecystokinin stimulated pancreatic exocrine secretion in health and disease.
    Clain JE; Barbezat GO; Waterworth MM; Bank S
    Digestion; 1978; 17(1):11-7. PubMed ID: 627317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of somatostatin analogue octreotide on amylase secretion from mouse pancreatic acini.
    Ishiguro H; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Sakai Y; Sobajima H; Nakae Y; Tanikawa M
    Digestion; 1993; 54(4):207-12. PubMed ID: 7694882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatostatin suppresses secretin and pancreatic exocrine secretion.
    Boden G; Sivitz MC; Owen OE; Essa-Koumar N; Landor JH
    Science; 1975 Oct; 190(4210):163-5. PubMed ID: 1166308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of parathyroid hormone on pancreatic exocrine secretion.
    Kuroda T; Shiohara E; Haba Y; Kaneko G; Hanazaki K; Kajikawa S; Iida F
    Pancreas; 1993 Nov; 8(6):732-7. PubMed ID: 7504820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of pancreatic secretion under long-term octreotide treatment in humans.
    Friess H; Bordihn K; Ebert M; Malfertheiner P; Kemmer T; Dennler HJ; Büchler MW
    Digestion; 1994; 55 Suppl 1():10-5. PubMed ID: 8132133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of methylated PGE2 analogs given orally on pancreatic response to secretin in man.
    Konturek SJ; Kwiecień N; Swierczek J; Oleksy J
    Am J Dig Dis; 1977 Jan; 22(1):16-9. PubMed ID: 13652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An important role of endogenous insulin on exocrine pancreatic secretion in rats.
    Lee KY; Zhou L; Ren XS; Chang TM; Chey WY
    Am J Physiol; 1990 Feb; 258(2 Pt 1):G268-74. PubMed ID: 1689549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exocrine pancreatic function after total gastrectomy.
    Gullo L; Costa PL; Ventrucci M; Mattioli S; Viti G; Labò G
    Scand J Gastroenterol; 1979; 14(4):401-7. PubMed ID: 482852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of plaunotol on release of plasma secretin and pancreatic exocrine secretion in humans.
    Shiratori K; Watanabe S; Takeuchi T; Chang JH; Moriyoshi Y
    Pancreas; 1989; 4(3):323-8. PubMed ID: 2471968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro inhibitory effect of somatostatin on secretin action in exocrine pancreas of rats.
    Matsushita K; Okabayashi Y; Hasegawa H; Koide M; Kido Y; Okutani T; Sugimoto Y; Kasuga M
    Gastroenterology; 1993 Apr; 104(4):1146-52. PubMed ID: 7681794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of secretin and cholecystokinin in oleic acid-stimulated pancreatic secretion in rats.
    Shiratori K; Watanabe S; Takeuchi T; Shimizu K; Moriyoshi Y
    Gastroenterol Jpn; 1990 Feb; 25(1):104-11. PubMed ID: 1689684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of verapamil on pancreatic exocrine secretion.
    Burns GP; Gersten M; Bank S; Stein TA; Zimmerman HM
    Surgery; 1986 Apr; 99(4):474-80. PubMed ID: 2420019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition by somatostatin of secretin-stimulated pancreatic secretion in man: a study with pure pancreatic juice.
    Domschke S; Domschke W; Rösch W; Konturek SJ; Sprügel W; Mitznegg P; Wünsch E; Demling L
    Scand J Gastroenterol; 1977; 12(1):59-63. PubMed ID: 189382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of intraduodenal oligopeptide on rat pancreatic exocrine secretion and release of secretin and CCK].
    Shimizu K
    Nihon Shokakibyo Gakkai Zasshi; 1990 Nov; 87(11):2509-16. PubMed ID: 1703583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of intraduodenal administration of pancreatic juice on the bile-induced pancreatic secretion and immunoreactive secretin release in man.
    Osnes M; Hanssen LE
    Scand J Gastroenterol; 1980; 15(8):1041-7. PubMed ID: 6165068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of secretin and vasoactive intestinal peptide on pancreatic secretion in dogs.
    Konturek SJ; Thor P; Dembinski A; Krol R
    Gastroenterology; 1975 Jun; 68(6):1527-35. PubMed ID: 1132634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of some N solutions for parenteral nutrition on gastric and pancreatic secretion.
    Stastná R; Skála I; Hrubá F; Shlygin GK; Sysoev Y
    Nutr Metab; 1979; 23(5):349-56. PubMed ID: 113712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inhibition by somatostatin of pancreatic juice and enzyme secretion and gallbladder contraction in man induced by secretin and cholecystokinin-pancreozymin administration (author's transl)].
    Creutzfeldt W; Lankisch PG; Fölsch UR
    Dtsch Med Wochenschr; 1975 May; 100(20):1135-8. PubMed ID: 1126301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.